Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

The compliance process at pharmaceutical manufacturers is complicated because many still use paper-based systems to record manufacturing steps. These paper records are reviewed by FDA auditors to ...

Pharmaceutical manufacturing steps are often isolated in space and time. The synthesis, isolation and purification of the drug substance (DS) and the formulation of the drug product (DP) may be ...

Granulation is a critical unit operation in pharmaceutical manufacturing, where fine powders are agglomerated into granules to improve flow properties, uniformity, and compaction performance. The ...

Continuous pharmaceutical manufacturing represents a significant shift from traditional batch processing, integrating continuous flow methods, advanced process analytical technology (PAT) and ...

In late December 2025, Charles Ross & Son promoted its five-cubic-foot double cone tumbler blender for small- to mid-scale ...

AI-driven decision engines and intelligent orchestration layers are crucial for navigating geopolitical risks and manufacturing inefficiencies in the pharmaceutical sector. Digital twins and unified ...

After inking and expanding a biosimilar production partnership with Pfizer this summer, Korea’s Samsung Biologics is boosting yet another Big Pharma manufacturing agreement. Monday, Samsung said it ...

Nagesh Nama, CEO, xLM. Nagesh Nama is a seasoned technology executive with over 30 years of experience in life sciences. The release of the European Medicines Agency's Annex 22 on artificial ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

India’s pharmaceutical industry is projected to target a size of $ 130 billion by 2030, more than double its current size of $ 58 billion in 2024. As the "Pharmacy of the World," India holds a unique ...